Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
1(4%)
Results Posted
40%(4 trials)
Terminated
3(13%)

Phase Distribution

Ph not_applicable
4
17%
Ph phase_2
2
9%
Ph phase_4
5
22%
Ph phase_3
9
39%
Ph phase_1
1
4%

Phase Distribution

1

Early Stage

2

Mid Stage

14

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
1(4.8%)
Phase 2Efficacy & side effects
2(9.5%)
Phase 3Large-scale testing
9(42.9%)
Phase 4Post-market surveillance
5(23.8%)
N/ANon-phased studies
4(19.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

10 of 16 finished

Non-Completion Rate

37.5%

6 ended early

Currently Active

1

trials recruiting

Total Trials

23

all time

Status Distribution
Active(3)
Completed(10)
Terminated(6)
Other(4)

Detailed Status

Completed10
unknown4
Terminated3
Withdrawn3
Not yet recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
1
Success Rate
76.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.8%)
Phase 22 (9.5%)
Phase 39 (42.9%)
Phase 45 (23.8%)
N/A4 (19.0%)

Trials by Status

terminated313%
completed1043%
not_yet_recruiting29%
withdrawn313%
unknown417%
recruiting14%

Recent Activity

1 active trials
Showing 5 of 23
not_yet_recruitingphase_3

Phenobarbital for Agitated Delirium

NCT07548489
not_yet_recruitingphase_4

Treatment of Seizures in Neonate With HIE

NCT07284498
completed

Population Pharmacokinetics of Antiepileptic in Pediatrics

NCT03196466
recruitingnot_applicable

Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures

NCT07098728
unknownphase_3

Lacosamide in Neonatal Status Epilepticus

NCT05291455
View all 23 trials

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT07548489Phase 3

Phenobarbital for Agitated Delirium

Not Yet Recruiting
NCT07284498Phase 4

Treatment of Seizures in Neonate With HIE

Not Yet Recruiting
NCT03196466

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed
NCT07098728Not Applicable

Levetiracetam Versus Phenobarbital in Benzodiazepines Unresponsive Paediatric Prolonged Seizures

Recruiting
NCT05291455Phase 3

Lacosamide in Neonatal Status Epilepticus

Unknown
NCT03670160Phase 2

Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome

Completed
NCT03632915

Pharmacokinetics of Antiepileptics in Patients on CRRT

Completed
NCT04156464Phase 4

Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit

Unknown
NCT02810782Phase 3

How to Treat Opiate Withdrawal in Neonates

Completed
NCT01958476Phase 3

Improving Outcomes in Neonatal Abstinence Syndrome

Completed
NCT03788889Phase 4

Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine

Withdrawn
NCT03025906Phase 2

Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus

Unknown
NCT00009620Phase 3

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Completed
NCT03650270Phase 3

Childhood Convulsive Status Epilepticus Management In A Resource Limited Setting

Completed
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT01284556Phase 3

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Completed
NCT02726867Phase 3

Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

Withdrawn
NCT03107507Phase 4

Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG

Unknown
NCT01089504Phase 4

Prophylactic Phenobarbital After Neonatal Seizures

Terminated
NCT00530413Not Applicable

Study of Phenobarbital Inhibition of Catamenial Epilepsy

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
23